Bharat Biotech conducts Covaxin trial on age group between 2 and 18

Hyderabad-based pharmaceutical company Bharat Biotech on Sunday launched the clinical trial of Covaxin on children in the age group of 12-18 years in Maharashtra’s second capital Nagpur.

Nagpur (Maharashtra):After getting permission from the Drug Controller General of India on Thursday,Hyderabad-based pharmaceutical company Bharat Biotech launched the clinical trial of Covaxin on children in the age group of 12-18 years in Maharashtra’s second capital Nagpur on Sunday.

The trial will be conducted at four locations across the country.

The trial was conducted at the Meditrina Hospital under the supervision of paediatrician Dr Vasant Khalatkar.

According to the sources, blood samples were collected from children between the age group of 12 and 18 years. A screening of 50 volunteers has been conducted and the clinical trials will begin after the blood reports are received.

Read: Covaxin will soon get EUL from WHO: Govt

The children are also counseled by the district administration before the vaccination process and after the vaccination, they will undergo an antibody test too.

Read: Plea in HC to stay Covaxin trial on children

The vaccination trial will be held in three phases. Children between the age group of 12-18 years will be given the jab first, followed by the 6-12 years age category, before inoculating children in the 2-6 years age bracket. Children with good results will be given a second dose after 28 days.

Read: Covid-19 vaccine: Bharat Biotech, Ocugen to commercialise Covaxin in Canada